Advisors Preferred, LLC Catalent, Inc. Transaction History

Advisors Preferred, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 26, 2021	SELL	$100.34 - $115.69 $1.05 Million - $1.21 Million	-10,466 Closed	0 $0
Q1 2021 May 07, 2021	SELL	$101.51 - $125.27 $866,083 - $1.07 Million	-8,532 Reduced 44.91%	10,466 $1.12 Million
Q4 2020 Feb 03, 2021	BUY	$85.88 - $105.36 $678,967 - $832,976	7,906 Added 71.28%	18,998 $1.97 Million
Q3 2020 Nov 12, 2020	BUY	$72.74 - $92.5 $806,832 - $1.03 Million	11,092 New	11,092 $950,000

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Advisors Preferred, LLC, based on Form 13F filings with the SEC.

Stay updated on Advisors Preferred, LLC with notifications on news.